Erlend Skaga

8PUBLICATIONS
21CO-AUTHORS
Disease surveillanceGene expression (incl. microarray and other genome-wide approaches)Epidemiological modellingPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2025
Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry.

Cassia Bree Trewin-Nybråten, Paul Christopher Lambert, Kirsten Marienhagen

|Dec 23, 2023
Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.

Marit Brynjulvsen, Elise Solli, Maria Walewska

|Nov 29, 2023
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study.

Eduardo Erasmo Mendoza Mireles, Erlend Skaga, Andres Server

|Mar 05, 2021
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

Erlend Skaga, Marthe Andrea Skretteberg, Tom Børge Johannesen

|Jun 25, 2020
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.

Kirsten Strømme Kierulf-Vieira, Cecilie Jonsgar Sandberg, Jo Waaler

|Jan 01, 2020
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.

Erlend Skaga, Evgeny Kulesskiy, Marit Brynjulvsen

Pageof 2

Frequent Collaborators

2 joint publications

Petter Brandal

2 joint publications

Einar Osland Vik-Mo

1 joint publications

Kirsten Strømme Kierulf-Vieira

1 joint publications

Eduardo Erasmo Mendoza Mireles